For All The Daily News, Views, & Trending Stories, Download in60 App Today!
medicine-in60-4.jpg Jul 19

Johnson & Johnson Sues Biden Administration Over Medicare Drug Price Negotiations

  • Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.  
  • The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. Constitution.
  • Earlier suits brought separately by Merck and Bristol Myers Squibb, as well as by the U.S. Chamber of Commerce and PhRMA, the pharmaceutical industry’s largest lobbying group, made similar arguments.